146 related articles for article (PubMed ID: 36509195)
1. Metformin inhibits oral squamous cell carcinoma progression through regulating RNA alternative splicing.
Ji M; Lv Y; Chen C; Xing D; Zhou C; Zhao J; Qi Y; Zhang J; Wang Y; Ma X; Xu W; Zhang W; Li X
Life Sci; 2023 Feb; 315():121274. PubMed ID: 36509195
[TBL] [Abstract][Full Text] [Related]
2. Identification of RNA-splicing factor Lsm12 as a novel tumor-associated gene and a potent biomarker in Oral Squamous Cell Carcinoma (OSCC).
Dong Y; Xue L; Zhang Y; Liu C; Zhang Y; Jiang N; Ma X; Chen F; Li L; Yu L; Liu X; Shao S; Guan S; Zhang J; Xiao Q; Li H; Dong A; Huang L; Shi C; Wang Y; Fu M; Lv N; Zhan Q
J Exp Clin Cancer Res; 2022 Apr; 41(1):150. PubMed ID: 35449073
[TBL] [Abstract][Full Text] [Related]
3. Research Progress of Metformin in the Treatment of Oral Squamous Cell Carcinoma.
Liu J; Zhao J; Qiao X
Endocrinology; 2023 Sep; 164(11):. PubMed ID: 37738154
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo synergistic anti-tumor effect of LIN28 inhibitor and metformin in oral squamous cell carcinoma.
Chen H; Sa G; Li L; He S; Wu T
Eur J Pharmacol; 2021 Jan; 891():173757. PubMed ID: 33249080
[TBL] [Abstract][Full Text] [Related]
5. LncRNA UCA1 promotes proliferation and cisplatin resistance of oral squamous cell carcinoma by sunppressing miR-184 expression.
Fang Z; Zhao J; Xie W; Sun Q; Wang H; Qiao B
Cancer Med; 2017 Dec; 6(12):2897-2908. PubMed ID: 29125238
[TBL] [Abstract][Full Text] [Related]
6. Palbociclib induces DNA damage and inhibits DNA repair to induce cellular senescence and apoptosis in oral squamous cell carcinoma.
Wang TH; Chen CC; Leu YL; Lee YS; Lian JH; Hsieh HL; Chen CY
J Formos Med Assoc; 2021 Sep; 120(9):1695-1705. PubMed ID: 33342707
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo anti-tumor effect of metformin as a novel therapeutic agent in human oral squamous cell carcinoma.
Luo Q; Hu D; Hu S; Yan M; Sun Z; Chen F
BMC Cancer; 2012 Nov; 12():517. PubMed ID: 23151022
[TBL] [Abstract][Full Text] [Related]
8. Identifying Drug Targets of Oral Squamous Cell Carcinoma through a Systems Biology Method and Genome-Wide Microarray Data for Drug Discovery by Deep Learning and Drug Design Specifications.
Lin YC; Chen BS
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142321
[TBL] [Abstract][Full Text] [Related]
9. Knock-down of ABCE1 gene induces G1/S arrest in human oral cancer cells.
Wang L; Zhang M; Liu DX
Int J Clin Exp Pathol; 2014; 7(9):5495-504. PubMed ID: 25337191
[TBL] [Abstract][Full Text] [Related]
10. Oxymatrine suppresses oral squamous cell carcinoma progression by suppressing CXC chemokine receptor 4 in an m
Luo R; Xie L; Lin Y; Shao J; Lin Z
Oncol Rep; 2022 Oct; 48(4):. PubMed ID: 36004481
[TBL] [Abstract][Full Text] [Related]
11. Long noncoding RNA TUG1 promotes proliferation, migration and cisplatin resistance in oral squamous cell carcinoma.
Liu S; Wang W; Ye L; Liu C; Xiao W; Gao J
Acta Biochim Biophys Sin (Shanghai); 2023 May; 55(8):1323-1326. PubMed ID: 37232574
[No Abstract] [Full Text] [Related]
12. Long noncoding RNA TFAP2A-AS1 promotes oral squamous cell carcinoma cell growth and movement via competitively binding miR-1297 and regulating TFAP2A expression.
Yang K; Niu Y; Cui Z; Jin L; Peng S; Dong Z
Mol Carcinog; 2022 Sep; 61(9):865-875. PubMed ID: 35730908
[TBL] [Abstract][Full Text] [Related]
13. Down-regulation of lncRNA HCG11 promotes cell proliferation of oral squamous cell carcinoma through sponging miR-455-5p.
Wu J; Li Y; Liu J; Xu Y
J Gene Med; 2021 Mar; 23(3):e3293. PubMed ID: 33151000
[TBL] [Abstract][Full Text] [Related]
14. Metformin inhibits proliferation of oral squamous cell carcinoma cells by suppressing proteolysis of nerve growth factor receptor.
Wei J; Huang J; Kuang Y; Li Y; Zhong D; Song J
Arch Oral Biol; 2021 Jan; 121():104971. PubMed ID: 33220581
[TBL] [Abstract][Full Text] [Related]
15. [Oral Squamous Cell Carcinoma-Derived Cell-Free DNA Modulates Stemness and Migration of Oral Squamous Cell Carcinoma Cell Line by Inducing M2 Macrophage Polarization].
Zheng SZ; Meng L; Ren FL; Ren CX; Li X; Wang DD; Sun HC
Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 May; 54(3):510-516. PubMed ID: 37248576
[TBL] [Abstract][Full Text] [Related]
16. Parathyroid hormone-related protein serves as a prognostic indicator in oral squamous cell carcinoma.
Lv Z; Wu X; Cao W; Shen Z; Wang L; Xie F; Zhang J; Ji T; Yan M; Chen W
J Exp Clin Cancer Res; 2014 Dec; 33(1):100. PubMed ID: 25539663
[TBL] [Abstract][Full Text] [Related]
17. Metformin increases PDH and suppresses HIF-1α under hypoxic conditions and induces cell death in oral squamous cell carcinoma.
Guimarães TA; Farias LC; Santos ES; de Carvalho Fraga CA; Orsini LA; de Freitas Teles L; Feltenberger JD; de Jesus SF; de Souza MG; Santos SH; de Paula AM; Gomez RS; Guimarães AL
Oncotarget; 2016 Aug; 7(34):55057-55068. PubMed ID: 27474170
[TBL] [Abstract][Full Text] [Related]
18. Inclusion of hnRNP L Alternative Exon 7 Is Associated with Good Prognosis and Inhibited by Oncogene SRSF3 in Head and Neck Squamous Cell Carcinoma.
Xu L; Shen J; Jia J; Jia R
Biomed Res Int; 2019; 2019():9612425. PubMed ID: 31828152
[TBL] [Abstract][Full Text] [Related]
19. miR-654-5p Targets GRAP to Promote Proliferation, Metastasis, and Chemoresistance of Oral Squamous Cell Carcinoma Through Ras/MAPK Signaling.
Lu M; Wang C; Chen W; Mao C; Wang J
DNA Cell Biol; 2018 Apr; 37(4):381-388. PubMed ID: 29364705
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of lncRNA HOXA-AS2 promotes the progression of oral squamous cell carcinoma by mediating SNX5 expression.
Li Z
BMC Mol Cell Biol; 2022 Dec; 23(1):59. PubMed ID: 36528556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
